OrganoClick AB (FRA:0CF) Cyclically Adjusted Revenue per Share: €0.09 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0CF OrganoClick AB FRA:0CF
25 GF Score
Price €0.02
GF Value €0.14
! 4 Warning Signs
View Full Analysis

What is OrganoClick AB Cyclically Adjusted Revenue per Share?

OrganoClick AB FRA:0CF -10.37% 25 Cyclically Adjusted Revenue per Share is €0.09 as of Mar. 2026. GuruFocus rates FRA:0CF with a GF Score™ of 25/100 and a GF Value™ of €0.14. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OrganoClick AB's adjusted revenue per share for the three months ended in Mar. 2026 was €0.023. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, OrganoClick AB's average Cyclically Adjusted Revenue Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-17), OrganoClick AB's current stock price is €0.0242. OrganoClick AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €0.09. OrganoClick AB's Cyclically Adjusted PS Ratio of today is 0.27.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OrganoClick AB was 4.41. The lowest was 0.29. And the median was 2.28.


OrganoClick AB  (FRA:0CF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OrganoClick AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.0242/0.09
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OrganoClick AB was 4.41. The lowest was 0.29. And the median was 2.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OrganoClick AB Cyclically Adjusted Revenue per Share Related Terms


OrganoClick AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for OrganoClick AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrganoClick AB Cyclically Adjusted Revenue per Share Chart

OrganoClick AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.09 0.09 0.10

OrganoClick AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.09 0.10 0.09

FRA:0CF vs LIN, SHW, ECL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, OrganoClick AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganoClick AB Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, OrganoClick AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OrganoClick AB's Cyclically Adjusted PS Ratio falls into.


FRA:0CF
25GF Score
OrganoClick AB FRA:0CF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrganoClick AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OrganoClick AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.023/133.5600*133.5600
=0.023

Current CPI (Mar. 2026) = 133.5600.

OrganoClick AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.027 101.019 0.036
201609 0.014 101.138 0.018
201612 0.010 102.022 0.013
201703 0.027 102.022 0.035
201706 0.042 102.752 0.055
201709 0.024 103.279 0.031
201712 0.017 103.793 0.022
201803 0.024 103.962 0.031
201806 0.040 104.875 0.051
201809 0.021 105.679 0.027
201812 0.017 105.912 0.021
201903 0.028 105.886 0.035
201906 0.040 106.742 0.050
201909 0.019 107.214 0.024
201912 0.016 107.766 0.020
202003 0.022 106.563 0.028
202006 0.037 107.498 0.046
202009 0.021 107.635 0.026
202012 0.019 108.296 0.023
202103 0.031 108.360 0.038
202106 0.041 108.928 0.050
202109 0.023 110.338 0.028
202112 0.018 112.486 0.021
202203 0.031 114.825 0.036
202206 0.037 118.384 0.042
202209 0.021 122.296 0.023
202212 0.020 126.365 0.021
202303 0.039 127.042 0.041
202306 0.036 129.407 0.037
202309 0.029 130.224 0.030
202312 0.025 131.912 0.025
202403 0.034 132.205 0.034
202406 0.035 132.716 0.035
202409 0.026 132.304 0.026
202412 0.019 132.987 0.019
202503 0.033 132.825 0.033
202506 0.028 133.699 0.028
202509 0.020 133.480 0.020
202512 0.015 133.390 0.015
202603 0.023 133.560 0.023

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.09 mean?
OrganoClick AB (FRA:0CF) has a Cyclically Adjusted Revenue per Share of €0.09 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on OrganoClick AB and its competitors.
Is OrganoClick AB's Cyclically Adjusted Revenue per Share too high?
OrganoClick AB's current Cyclically Adjusted Revenue per Share is €0.09. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Cyclically Adjusted Revenue per Share compare to LIN and SHW?
OrganoClick AB's Cyclically Adjusted Revenue per Share of €0.09 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on OrganoClick AB and its competitors. OrganoClick AB's current Cyclically Adjusted Revenue per Share is €0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current Cyclically Adjusted Revenue per Share of €0.09. The stock's GF Value™ is €0.14, compared to a current price of €0.02 — trading 82.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.09. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current Cyclically Adjusted Revenue per Share is €0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrganoClick AB (FRA:0CF) Overvalued in 2026?

Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued. The current stock price of €0.02 is trading 82.7% below its estimated GF Value™ of €0.14.

Key valuation signals for FRA:0CF:

  • Cyclically Adjusted Revenue per Share: €0.09
  • GF Value™: €0.14 vs. price of €0.02 (82.7% below fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrganoClick AB Business Description

Other Exchanges ORGC:Sweden
Address Linjalvagen 9, Taby, SWE, SE-187 66
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score

Get the complete analysis for FRA:0CF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.14
GF Value